Active Supportive Care and Symptom Management Grants

PI Namesort descending Organization - Company Title FOA
Damaj, M. Imad Virginia Commonwealth University Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross PA-16-188: Mechanisms, Models, Measurement, and Management in Pain Research
Dantzer, Robert University Of Tx Md Anderson Can Ctr The Metabolic Basis of Cancer-Related Fatigue PA-18-484: NIH Research Project Grant
Darmani, Nissar A Western University Of Health Sciences Substance P tachykininergic NK1 receptor emetic signal transduction pathways PA-16-160: NIH Research Project Grant
Dougherty, Patrick M University Of Tx Md Anderson Can Ctr The role of ENF loss, TLR4 and spinal plasticity in paclitaxel CIPN PA-13-302: Research Project Grant
El-Jawahri, Areej Massachusetts General Hospital Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation PA-16-160: NIH Research Project Grant
Enzinger, Andrea C Dana-Farber Cancer Inst Development of A Mindfulness-Based Mobile Health Intervention for Patients Coping with Pain from Advanced Malignancies PA-18-946: Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain
Fortier, Michelle University Of California-Irvine Innovative Pain and Symptom Management Program for Children with Cancer PA-16-160: NIH Research Project Grant
Geisler, Stefanie Washington University Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
Geisler, Stefanie Washington University Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies
Gewandter, Jennifer University Of Rochester Wireless transcutaneous electrical stimulation (TENS) for chemotherapy-induced peripheral neuropathy: A phase II randomized clinical trial PA-18-159: Mechanisms, Models, Measurement, and Management in Pain Research
Goode, Diana J University Of New England Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy PA-20-185: NIH Research Project Grant
Grace, Peter University Of Tx Md Anderson Can Ctr PQ12 Targeting HDAC6 for Chemotherapy-Induced Neuropathy and Chemobrain RFA-CA-17-017: Research Answers to NCI's Provocative Questions
Gray, Robert J Dana-Farber Cancer Inst Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability
Grueber, Wesley B Columbia University Health Sciences Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Hanks, Brent Allen Duke University Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies

Pages